Centre for new antibacterial strategies (CANS) is a new, large interdisciplinary centre at UiT – The Arctic University of Norway for research, education, innovation and dissemination related to antimicrobial resistance (AMR). CANS currently involves sixteen research groups located at three faculties and covers topics within marine bioprospecting – identification and characterization of new antibacterial activities, design and synthesis of new antibiotics and resistance inhibitors, the evolution and molecular epidemiology of AMR, host-microbe-drug interactions, and antibiotic stewardship.
The centre aims to strengthen current activities, but also support new basic research in novel concepts for sustainable antibacterial activities in AMR-prevention and treatment strategies through new permanent and temporary (tenure-track, postdoc and PhD) positions.
CANS, as part of the Network of Nordic AMR Centers, invites researchers, PhDs and postdocs from all Nordic AMR Centres to a conference in Tromsø from 13 to 15 March 2024. There will be lectures, posters and an exciting mixture of networking and cross-disciplinary discussions. Full programme to be announced.
One of the discoveries of 2022. Theresa Wagner found out that bacteria can hide their antibiotic resistance properties, until they are needed to defend the bacteria. Foto: Jan Fredrik Frantzen, UiTLink to this page
Probiotics create order in preterm babies' gut, fight antimicrobial resistance as a bonus
There are even more positives to probiotics than previously thought. As well as helping preterm babies gain a healthy gut microbiome, they reduce the chance of harmful bacteria building resistance to antibiotics.
After analyzing stool samples from 72 premature babies over the course of their first year, researchers (from left) Claus Klingenberg, Ahmed Bargheet and Veronika K. Pettersen have found that probiotics really have benefits for those extremely young. Foto: Jan Fredrik Frantzen, UiT
Every year about 15 million preterm babies are born worldwide who suffer from a risk of infection and inflammation. Being born many weeks or even months before their expected due date, their immune system is less mature than in term babies, including impaired gut barrier function and quite different microbial community in the large intestine.
Giving antibiotics to preterm infants disrupts the maturing process of the gut microbiome, and makes them more vulnerable to antimicrobial resistant variants of harmful bacteria.
Researchers at UiT The Arctic University of Norway have found that probiotics help preterm babies achieve a better bacterial balance in the gut and eradicate harmful bacteria, as the under-developed gut microbiome works its way into maturity.
Helping preterm babies catch up with their fellow newborns
The researchers behind the study used data from a clinical trial where stool samples were collected four times in the first year of life from 72 babies in six Norwegian neonatal intensive care units. They then divided the samples into groups depending on whether the newborns were given antibiotics, a combination of antibiotics and probiotics, or none. The microbial DNA in the samples was sequenced to follow the development of the babies’ gut microbiota.
The study supports the findings of other recent studies showing that probiotics boost normal microbiota and maturation in preterm infants to levels comparable to full-term newborns.
Less antimicrobial resistance
But there is also another finding that should be very interesting to medical staff around the world fighting antimicrobial resistance, or AMR. With probiotics, the extremely preterm infants had decreased risk of carrying antimicrobial resistant bugs despite frequent treatment with antibiotics.
- We discovered that probiotic-supplemented preterm newborns have bacteria that carry substantially fewer antibiotic-resistance genes, than infants that did not get probiotic supplements, says doctoral research fellow Ahmed Bargheet, the first author of the study.
About the study
The study was carried out at the Pediatric Research Group for Infections and Host-Microbe Interaction Research Group at the Centre for New Antibacterial Strategies (CANS), UiT The Arctic University of Norway. The work was done in cooperation with the University Hospital of North Norway and funded by the Odd Berg Group, the Northern Norway Regional Health Authority and Tromsø Research Foundation.
Probiotics are live bacteria and yeasts promoted as having various health benefits. They're usually added to yoghurts or taken as food supplements, and are often described as "good" or "friendly" bacteria: https://www.nhs.uk/conditions/probiotics/
The microbiome explained
Picture a bustling city on a weekday morning, the sidewalks flooded with people rushing to get to work or to appointments. Now imagine this at a microscopic level and you have an idea of what the microbiome looks like inside our bodies, consisting of trillions of microorganisms (also called microbiota or microbes) of thousands of different species: https://www.hsph.harvard.edu/nutritionsource/microbiome/
Where: UiT - The Arctic University of Norway – Tromsø
When: May 14. 2026 at 09:00 – 15:00
We are delighted to announce the Arctic Biofilm symposium, which is to be arranged at UiT - The Arctic University of Norway 14-15th of June 2023.
During these two days different aspects of bacterial biofilms will be highlighted, such as basic research on biofilm evolution as well as how biofilms represent a clinical problem and treatment of biofilm-associated infections.
Talks will be given by international experts in the field, as well as local contributors, see preliminary program attached.
Please sign up for two inspiring days. The symposium is free of charge, but we need you to sign up in order to order lunch.